BIONDVAX completes a Phase 2 trial

WSJ has a general COVID VACCINE article:

https://www.wsj.com/articles/coronavirus-vaccine-candidates-pivotal-u-s-testing-to-start-this-summer-11591781405?mod=hp_lead_pos3.

Looks like a positive day for COVID VACCINE stocks with a better than 2 -1 ratio of stocks pointing to a higher open. The star today may be 

BIONDVAX (BVXV) whichhas completed a Phase 2 Clinical Study Report. Looking for a Plus 10% open this morning.

http://www.biondvax.com/2020/06/nih-report-on-phase-2-clinical-trial-of-biondvaxs-m-001-universal-influenza-vaccine-candidate-concludes-both-primary-endpoints-achieved/

GOVX: https://finance.yahoo.com/news/geovax-present-covid-19-vaccine-130010714.html.

JAPAN: https://finance.yahoo.com/news/japans-anges-speeds-towards-2021-080652121.html